Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Change in Inventory (2016 - 2025)

Fortress Biotech has reported Change in Inventory over the past 10 years, most recently at -$2.2 million for Q4 2025.

  • Quarterly results put Change in Inventory at -$2.2 million for Q4 2025, down 183.01% from a year ago — trailing twelve months through Dec 2025 was -$4.8 million (down 213.78% YoY), and the annual figure for FY2025 was -$4.8 million, down 213.78%.
  • Change in Inventory for Q4 2025 was -$2.2 million at Fortress Biotech, down from -$1.0 million in the prior quarter.
  • Over the last five years, Change in Inventory for FBIO hit a ceiling of $12.0 million in Q2 2021 and a floor of -$2.7 million in Q3 2021.
  • Median Change in Inventory over the past 5 years was -$852000.0 (2022), compared with a mean of $108950.0.
  • Peak annual rise in Change in Inventory hit 2632.73% in 2021, while the deepest fall reached 1620.38% in 2021.
  • Fortress Biotech's Change in Inventory stood at -$1.8 million in 2021, then skyrocketed by 38.87% to -$1.1 million in 2022, then grew by 23.62% to -$818000.0 in 2023, then skyrocketed by 423.11% to $2.6 million in 2024, then tumbled by 183.01% to -$2.2 million in 2025.
  • The last three reported values for Change in Inventory were -$2.2 million (Q4 2025), -$1.0 million (Q3 2025), and $356000.0 (Q2 2025) per Business Quant data.